Santa Cruz Biotechnology

c-Myc (N-262)

#sc-764 · western blot

164
Citing papers
10.9k
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways10Chromatin Remodeling and Cancer7Ubiquitin and proteasome pathways7Protein Degradation and Inhibitors6Epigenetics and DNA Methylation6Cancer Mechanisms and Therapy5Genomics and Chromatin Dynamics5MicroRNA in disease regulation5

Papers citing this product

1
Chromatin structure analyses identify miRNA promoters
Genes & Development·2008·666 cit.·DOI
2
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets
Genome biology·2003·489 cit.·DOI
3
The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence
Aging Cell·2011·343 cit.·DOI
4
REST maintains self-renewal and pluripotency of embryonic stem cells
Nature·2008·342 cit.·DOI
5
Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production
Molecular Medicine·1998·332 cit.·DOI
6
Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
PLoS ONE·2008·322 cit.·DOI
7
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Journal of Clinical Investigation·2018·260 cit.·DOI
8
The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies
Nature Communications·2017·221 cit.·DOI
9
p53 Activation in Adipocytes of Obese Mice
Journal of Biological Chemistry·2003·215 cit.·DOI
10
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Nature Communications·2017·207 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.